Compile Data Set for Download or QSAR
Report error Found 915 Enz. Inhib. hit(s) with Target = 'Pantetheinase'
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480973(US10906888, Example 190)
Affinity DataKd:  20nMAssay Description:Binding affinity to recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells assessed as dissociation constant by surface plasmon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480978(US10906888, Example 196 | US10906888, Example 197 ...)
Affinity DataKd:  7.20nMAssay Description:Binding affinity to recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells assessed as dissociation constant by surface plasmon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480981(US10906888, Example 200 | US10906888, Example 199 ...)
Affinity DataKd:  37nMAssay Description:Binding affinity to recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells assessed as dissociation constant by surface plasmon...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717811(1-(1-(2-fluorobenzoyl)-1H-pyrrol-3-yl)-2-phenyleth...)
Affinity DataKd:  300nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717812(US20250042850, Compound 2)
Affinity DataKd:  300nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717813(1-(1-(2,6-difluorobenzyl)-1H-pyrrol-3-yl)-2-phenyl...)
Affinity DataKd: >500nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717814(1-(5-(2-fluorobenzoyl)-1-methyl-1H-pyrrol-2-yl)-2-...)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717815(1-(5-(2-fluorobenzoyl)-1H-pyrrol-3-yl)-2-phenyleth...)
Affinity DataKd: >500nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717816(4-(2-fluorobenzoyl)-1-methyl-1H-pyrrole-2-carboxyl...)
Affinity DataKd: >500nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717817(1-(5-(2-fluorobenzoyl)-1-methyl-1H-pyrrol-3-yl)-2-...)
Affinity DataKd: >500nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717818(1-(1-methyl-5-picolinoyl-1H-pyrrol-2-yl)-2-phenyle...)
Affinity DataKd:  300nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717819((4-(2-fluorobenzoyl)-1-methyl-1H-pyrrol-2-yl) (8-o...)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717820((R)—N-(1-(4-(2-fluorobenzoyl)-1-methyl-1H-pyrrole-...)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717821((5-(2-fluorobenzoyl)-1-methyl-1H-pyrrol-2-yl) (8-o...)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717822(N-(tert-butyl)-5-(2-fluorobenzoyl)-1-methyl-1H-pyr...)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717823(US20250042850, Compound 5)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717824(US20250042850, Compound 9)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717825(US20250042850, Compound 10)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717826(US20250042850, Compound 13)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717827(US20250042850, Compound 14)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717828(US20250042850, Compound 16)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717829(US20250042850, Compound 20)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717830(US20250042850, Compound 21)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717831(US20250042850, Compound 26)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717832(US20250042850, Compound 23)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717833(US20250042850, Compound 24)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM717834(US20250042850, Compound 27)
Affinity DataKd: <100nMAssay Description:Table 1 and 5: Test compounds were prepared as 111X stocks in 100% DMSO. Kd values were determined using an 11-point 3-fold compound dilution series ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50585537(CHEMBL5084938)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells using Pantetheine-7-amino-4-trifluoromethykournarin as sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480924(US10906888, Example 138)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells using Pantetheine-7-amino-4-trifluoromethykournarin as sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480916(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[1-(pyrazin-2-yl)...)
Affinity DataIC50: 0.0410nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480924(US10906888, Example 138)
Affinity DataIC50: 0.0430nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480965(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[2-(pyrazin-2-yl)...)
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells using Pantetheine-7-amino-4-trifluoromethykournarin as sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480965(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[2-(pyrazin-2-yl)...)
Affinity DataIC50: 0.0620nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480929(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[2-(pyrimidin-5-y...)
Affinity DataIC50: 0.0800nMAssay Description:Inhibition of recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells using Pantetheine-7-amino-4-trifluoromethykournarin as sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480929(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[2-(pyrimidin-5-y...)
Affinity DataIC50: 0.0820nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480917(7-oxa-2-azaspiro[3.5]non-2-yl(2-{[2-(pyrazin-2-yl)...)
Affinity DataIC50: 0.0940nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM408834(US10364255, Ex. 25)
Affinity DataIC50: 0.100nMAssay Description:Method 1:Vanin-1 Enzymatic Assay:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2020
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475856(US10864201, Ex. 4.1)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475858(US10864201, Ex. 4.3)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475859(US10864201, Ex. 4.4)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475861(US10864201, Ex. 5.2)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475862(US10864201, Ex. 5.3)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475869(US10864201, Ex. 7.1)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475870(US10864201, Ex. 7.2)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475872(US10864201, Ex. 7.4)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475874(US10864201, Ex. 8.2)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475875(US10864201, Ex. 8.3)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM475883(US10864201, Ex. 9.1)
Affinity DataIC50: 0.100nMAssay Description:The test compounds are dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/18/2021
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM668454(US20240124479, Compound 38)
Affinity DataIC50: 0.100nMAssay Description:A certain mass of the compound was weighed precisely, and prepared with DMSO and reaction buffer (50 mM Tris base, 50 mM KCl, 1.6 mM cysteamine, 0.00...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetPantetheinase(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM480917(7-oxa-2-azaspiro[3.5]non-2-yl(2-{[2-(pyrazin-2-yl)...)
Affinity DataIC50: 0.110nMAssay Description:Inhibition of recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells using Pantetheine-7-amino-4-trifluoromethykournarin as sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
Displayed 1 to 50 (of 915 total ) | Next | Last >>
Jump to: